| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $118.7M | +15.6% | +146.7% |
| R&D Expense | $16.3M | +4.4% | +34.3% |
| SG&A Expense | $108.6M | +5.5% | +87.6% |
| Operating Income | -$14.5M | +34.5% | +42.3% |
| Interest Expense | $2.3M | +1.3% | -7.2% |
| Net Income | -$12.6M | +38.1% | +46.3% |
| EPS (Basic) | -$0.30 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $112.7M | +16.6% | -36.0% |
| Short-term Investments | $289.1M | +1.6% | +105.4% |
| Accounts Receivable | $72.6M | +24.5% | +149.0% |
| Inventory | $3.8M | -1.0% | +34.8% |
| Current Assets | $501.7M | +5.7% | +40.5% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$31.8M | — | — |
| Capital Expenditures | $3.5M | — | — |
| Investing Cash Flow | -$91.4M | — | — |
| Financing Cash Flow | $141.1M | — | — |
| Free Cash Flow | -$35.3M | — | — |
| +37.5% |
| +50.8% |
| EPS (Diluted) | -$0.30 | +37.5% | +50.8% |
| $534.6M |
| +8.0% |
| +42.1% |
| Current Liabilities | $117.0M | +29.7% | +77.7% |
| Long-term Debt | $72.3M | +0.2% | +0.8% |
| Total Liabilities | $199.5M | +22.8% | +43.7% |
| Stockholders' Equity | $335.1M | +0.7% | +41.1% |